
Dana-Farber Lank Center for Genitourinary Oncology Research Digest
Dana-Farber Lank Center for Genitourinary Oncology shared a post on X:
“GU Research Digest for the week of February 8 – 14: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on http://pubmed.ncbi.nlm.nih.gov to read!”
Genitourinary/Immunotherapy/General
Renal
Authors: Mohammad Jad Moussa et al.
Authors: Andrew Dhawan et al.
BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma.
Authors: Chengheng Liao, et al.
Bladder/Urothelial
Authors: Nadine Houédé et al.
Sacituzumab govitecan in advanced urothelial carcinoma: TROPICS- 04, a phase III randomized trial.
Authors: Thomas Powles et al.
Authors: Aung Naing et al.
Prostate
Authors: Louise Emmett L, et al.
Authors: Rachel R Xiang, et al.
Combination Therapies in Locally Advanced and Metastatic Hormone- sensitive Prostate Cancer.
Authors: Arun A. Azad et al.
The Germline and Somatic Origins of Prostate Cancer Heterogeneity.
Authors: Takafumi N Yamaguchi et al.
Effective Treatment of Disseminated Prostate Cancer Using CD46- Targeted 225Ac Therapy.
Authors: Anil P Bidkar et al.
Authors: Daniel Magee et al.
Authors: Thomas J. Hoffmann et al.
Targeting ADAR1 with a small molecule for the treatment of prostate cancer.
Authors: Xiao Wang et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023